How Can Routine Clinical Laboratories Keep Up with the Opioid Crisis?

Abstract

Opioid-related overdoses and deaths have grown to epidemic proportions throughout the United States and Canada, and are increasing elsewhere in the world as well Despite targeted efforts such as naloxone distribution and prescription drug monitoring programs, progress toward reversing these trends has been slow On the contrary, many areas are reporting staggering increases in overdoses and drug-related deaths during the COVID-19 pandemic [truncated]